0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Editor's Note |  FREE ONLINE FIRST
Charles R. Thomas Jr, MD
JAMA Oncol. Published online April 16, 2015. doi:10.1001/jamaoncol.2015.0514

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Wendy E. Barrington, PhD; Jeannette M. Schenk, PhD; Ruth Etzioni, MD; et al.
JAMA Oncol. Published online April 16, 2015. doi:10.1001/jamaoncol.2015.0513
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  FREE ONLINE FIRST
William D. Figg, PharmD, MBA; Ian M. Thompson, MD
JAMA Oncol. Published online April 02, 2015. doi:10.1001/jamaoncol.2015.0408

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Laurent Azoulay, PhD; Maria Eberg, MSc; Serge Benayoun, MD, MSc; et al.
JAMA Oncol. Published online April 02, 2015. doi:10.1001/jamaoncol.2015.0387
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  FREE
Sandip M. Prasad, MD, MPhil; A. Oliver Sartor, MD; Charles L. Bennett, MD, PhD
JAMA Oncol. 2015;1(1):67-68. doi:10.1001/jamaoncol.2014.183.

JAMA Oncology | 
Original Investigation |  FREE
Chenjie Zeng, MPH; Wanqing Wen, MD, MPH; Alicia K. Morgans, MD; et al.
JAMA Oncol. 2015;1(1):88-96. doi:10.1001/jamaoncol.2014.161.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  FREE
Karim Chamie, MD; Stephen B. Williams, MD; Jim C. Hu, MD, MPH
JAMA Oncol. 2015;1(1):60-67. doi:10.1001/jamaoncol.2014.192.

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Susan G. Lakoski, MD, MS; Benjamin L. Willis, MD; Carolyn E. Barlow, MS; et al.
JAMA Oncol. Published online March 26, 2015. doi:10.1001/jamaoncol.2015.0226

JAMA Oncology | 
Invited Commentary |  FREE ONLINE FIRST
Samuel Swisher-McClure, MD, MSHP; Justin Bekelman, MD
JAMA Oncol. Published online March 12, 2015. doi:10.1001/jamaoncol.2015.31

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Danil V. Makarov, MD, MHS; Pamela R. Soulos, MPH; Heather T. Gold, PhD; et al.
JAMA Oncol. Published online March 12, 2015. doi:10.1001/jamaoncol.2015.37
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editor's Note  | 
Targeted Reduction in Body Mass Index Is a Worthwhile Risk Reduction Strategy for Prostate Cancer
Charles R. Thomas Jr, MD
JAMA Oncology
Original Investigation  | 
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Wendy E. Barrington, PhD; Jeannette M. Schenk, PhD; Ruth Etzioni, MD; et al.
JAMA Oncology
Invited Commentary  | 
Effect of 5α-Reductase Inhibitor Use on Mortality From Prostate Cancer
William D. Figg, PharmD, MBA; Ian M. Thompson, MD
JAMA Oncology
Original Investigation  | 
5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer
Laurent Azoulay, PhD; Maria Eberg, MSc; Serge Benayoun, MD, MSc; et al.